|
1) Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a Pediatric Nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000; 105: 1242-9
|
|
|
|
2) 本山 治, 重富ゆかり, 飯高喜久雄. 小児期ステロイド依存性ネフローゼ症候群におけるシクロスポリン療法の検討. 全血monoclonal RIA法による血中濃度と成長における効果. 日児誌. 1997; 101: 1303-7
|
|
|
|
|
3) Avioli LV. Glucocorticoid effects on statural growth. Br J Rheumatol. 1993; 32 Suppl 2: 27-30
|
|
|
|
|
|
4) Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid-responsive nephrotic syndrome. Lancet. 1985; 2: 917-9
|
|
|
|
|
|
5) Kashtan C, Melvin T, Kim Y. Long-term follow-up of patients with steroid-dependent minimal change nephrotic syndrome. Clin Nephrol. 1988; 29: 79-85
|
|
|
|
|
|
6) 北村満左代. 小児の頻回再発型ネフローゼにおけるステロイド低身長の研究. 日腎誌. 1992; 34: 117- 24
|
|
|
|
|
|
7) Motoyama O, Iitaka K. Final height in children with steroid-sensitive nephritic syndrome. Pediatr Int. 2007; 49: 623-5
|
|
|
|
|
|
8) Ruth EM, Kemper MJ, Leumann EP, et al. Children with steroid-sensitive nephrotic syndrome. Come of age: Long-term outcome. J Pediatr. 2005; 147: 202-7
|
|
|
|
|
|
9) Foster BJ, Shults J, Zemel BS, et al. Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr. 2004; 80: 1334-41
|
|
|
|
|
|
10) Saha MT, Laippala P, Lenko HL. Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone. Acta Paediatr. 1998: 87: 545-8
|
|
|
|
|
|
11) Scharer K, Essigmann HC, Schaefer F. Body growth of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 1999; 13: 828-34
|
|
|
|
|
|
12) Lee DY, Park SK, Kim JS. Insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children with nephrotic syndrome. J Clin Endocrinol Metab. 1996; 81: 1856-60
|
|
|
|
|
|
13) Haffner D, Tonshoff B, Blum WF, et al. Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children. Kidney Int. 1997; 52: 802-10
|
|
|
|
|
|
14) Kapila P, Jones J, Rees L. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis. Pediatr Nephrol. 2001; 16: 1099-104
|
|
|
|
|
|
15) Pennisi AJ, Costin G, Phillips LS, et al. Somatomedin and growth hormone stadies, in pediatric renal allograft recipients who receive daily prednisone. Am J Dis Child. 1979; 133: 950-4
|
|
|
|
|
|
16) Betts RP, Magrath G. Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J. 1974; 2: 189-93
|
|
|
|
|
|
17) Rees L, Greene SA, Adlard P, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child. 1988; 63: 484-90
|
|
|
|
|
|
18) Mushtaq T, Ahmed SF. The impact of corticosteroids on growth and bone health. Arch Dis Child. 2002; 87: 93-6
|
|
|
|
|
|
19) Leonard MB, Feldman HI, Shults J, et al. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med. 2004; 351: 868-75
|
|
|
|
|
|
20) 田中敏章, 今井敏子. 縦断的検討による女児の思春期の成熟と初経年齢の標準化. 日児誌. 2005; 109: 1232-42
|
|
|
|
|
|
21) Motoyama O, Hasegawa A, Ohara T, et al. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: Results obtained between 1990 and 2003. Pediatr Transplant. 2005; 9: 232-8
|
|
|
|
|
|
22) Donatti TL, Koch VH, Fujimura MD, et al. Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol. 2003; 18: 789-95
|
|
|
|
|
|
23) Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2003; 18: 783-8
|
|
|
|
|
|
24) Fakhouri F, Bocquet N, Taupin P, et al. Steroid-sensitive nephrotic syndrome: From childhood to adulthood. Am J Kidney Dis. 2003; 41: 550-7
|
|
|
|
|
|
25) Matsukura H, Inaba S, Shinozaki K, et al. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome. Am J Nephrol. 2001; 21: 362-7
|
|
|
|
|
|
26) 下村英毅, 前 寛, 柴野貴之, 他. 最終身長までフォローできた成長ホルモン分泌不全性低身長を合併したネフローゼ症候群の治療成績. 日児腎誌. 2008; 21: 22-8
|
|
|
|
|
|
27) Allen DB, Julius JR, Breen TJ, et al. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study. J Clin Endocrinol Metab. 1998; 83: 2824-9
|
|
|
|
|
|
28) Rivkees SA, Danon M, Herrin J. Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. J Pediatr. 1994; 125: 322-5
|
|
|
|
|
|
29) Latta K, von Schnakenburg C, Ehrich JHH. A meta-analysis of cytotoxic treatment for frequently relapsing nephritic syndrome in children. Pediatr Nephrol. 2001; 16: 271-82
|
|
|
|
|
|
30) 後藤美和, 池田昌弘, 幡谷浩史, 他. 小児頻回再発型ネフローゼ症候群に対するミゾリビン高用量治療の再発抑制効果と安全性. 日腎誌. 2006; 48: 365-70
|
|
|
|
|
|
31) Fujinaga S, Kaneko K, Muto T, et al. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child. 2006; 91: 666-70
|
|
|
|
|
|
32) Sinha MD, MacLeod R, Rigby E, et al. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant. 2006; 21: 1848-54
|
|
|
|
|
|
33) Novak I, Frank R, Vento S, et al. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2005; 20: 1265-8
|
|
|
|
|
|
34) Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med. 2007; 356: 2751-2
|
|
|
|
|
|
35) Motoyama O, Shigetomi Y, Sawai K, et al. Convulsion during cyclosporin A therapy for nephrotic syndrome. Clin Exp Nephrol. 2000; 4: 63-6
|
|
|
|
|